Expression of signal transducing T-cell receptor ζ molecules after adoptive immunotherapy in patients with gastric and colon cancer

International Journal of Cancer

Volumn 78, Issue 3, 1998, Pages 301-305

  Kono, Koji ^a   Ichihara, Fumiko ^a   Iizuka, Hidehiko ^a   Sekikawa, Takayoshi ^a   Matsumoto, Yoshiro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; ARTICLE; ASCITES; CANCER GROWTH; CANCER INFILTRATION; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; IMMUNOMODULATION; LYMPHOCYTE SUBPOPULATION; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA; TREATMENT OUTCOME; TUMOR ASSOCIATED LEUKOCYTE;

ADENOCARCINOMA; AGED; ASCITES; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PLEURAL EFFUSION; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 0032578693     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981029)78:3<301::AID-IJC7>3.0.CO;2-Z     Document Type: Article

References (22)

1. AEBERSOLD, P., HYATT, C., JOHNSON, S., HINES, K., KORCAK, L., SANDERS, M., LOTZE, M., TOPALIAN, S., YANG, J. and ROSENBERG, S.A., Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response. J. nat. Cancer Inst., 83, 932-937 (1991).
2. FARACE, F., ANGEVIN, E., VANDERPLANCKE, J., ESCUDIER, B. and TRIEBEL F., The decreased expression of CD3 ζ chains in cancer patients is not reversed by IL-2 administration. Int. J. Cancer, 59, 752-755 (1994).
3. FINKE, J.H., ZEA, A.M., STANLEY, J., LONGO, D.J., MIZOGUCHI, H., TUBES, R.R., WILTROUT, R.H., O'SHEA, J.J., KUDOH, S., KLEIN, E., BUKOWSKI, R.M. and OCHOA, A.C., Loss of T-cell receptor ζ chain and p561ck in T-cells infiltrating human renal cell carcinoma. Cancer Res., 53, 5613-5616 (1993).
4. GOEDEGEBUURE, P.S., DOUVILLE, L.M., LI, H., RICHMOND, G.C., SCHOOF, D.D., SCAVONE, M. and EBERLEIN, T.J., Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma. J. clin. Oncol., 13, 1939-1949 (1995).
5. GOHARA, R., NAKAO, M., OGATA, Y., ISOMOTO, H., OIZUMI, K. and ITOH, K., Histocompatibility leukocyte antigen-A2402-restricted cytotoxic T lymphocytes recognizing adenocarcinoma in tumor-infiltrating lymphocytes of patients with colon cancer. Jpn. J. Cancer Res., 88, 198-204 (1997).
6. IKEDA, H., SATO, N., MATSUURA, A. and KIKUTI, K., Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinoma. Cancer Res., 53, 3078-3084 (1993).
7. IRVING, B.A. and WEISS, A., The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways. Cell, 64, 891-901 (1991).
8. ITOH, K., PLATSOUCAS, C.D. and BALCH, C.M., Autologous tumor-specific cytotoxie T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin-2 and autologous tumor cells, and involvement of the T cell receptor. J. exp. Med., 168, 1419-1425 (1988).
9. + T cells derived from solid tumor, metastatic lymph nodes and ascites in patients with gastric cancer. Int. J. Cancer, 71, 978-981 (1997).
10. KONO, K., RESSING, M.E., BRANDT, R.M.P., MELIEF, C.J.M., POTKUL, R.K., ANDERSSON, B., PETERSSON, M., KAST, W.M. and KIESSLING, R., Decreased expression of signal transducing ζ chains on peripheral T cells and NK cells in patients with cervical cancer. Clin. Cancer Res., 2, 1825-1828 (1996a).
11. KONO, K., SALAZAR, F., PETERSSON, M., HANSSON, J., MASUCCI, G., WASSERMAN, K., NAKAZAWA, T., ANDERSON, P. and KIESSLING, R., Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell- and NK-mediated cytotoxicity. Europ. J. Immunol., 26, 1308-1313 (1996b).
12. MISE, K., KAN, N., OKINO, T., MORIGUCHI, Y., HARADA, T., ICHINOSE, Y. and INOUE, K., OK-432-combined adoptive immunotherapy as a prognostic factor in peritoneal metastasis from gastric cancer. Surgery Today, 24, 54-58 (1994).
13. NAKAGOMI, H., PETERSSON, M., MAGNUSSON, I., JUHLIN, C., MATSUDA, M., MELLSTEDT, H., TAUPIN, J.L., VIVIER, E., ANDERSON, P. and KIESSLING, R., Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T cells and NK cells of patients with colorectal carcinoma. Cancer Res., 53, 5610-5612 (1993).
14. OHTSUJI, M., KIMURA, Y., AOE, T., OKAMOTO, Y. and SAITO, T., Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 ζ chain of T-cell receptor complex and antigen-specific T-cell responses. Proc. nat. Acad. Sci. (Wash.), 93, 13119-13124 (1996).
15. PEOPLE, G.E., GOEDEGEBUURE, P.S., ANDREWS, J.V.R., SCHOOF, D.D. and EBERLEIN, T.J., HLA-A2 presents shared tumor-associated antigens derived from endogenous proteins in ovarian cancer. J. Immunol., 151, 5481-5491 (1993).
16. RABINOWICH, H., BANKS, M., REICHERT, T.E., LOGAN, T.F., KIRKWOOD, J.M. and WHITESIDE, T.L., Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy. Clin. Cancer Res., 2, 1263-1274 (1996).
17. RATTO, G.B., ZINO, P., MIRABELLI, S., MINUTI, P., AQUILINA, R., FRANTINO, G., SPESSA, E., PONTE, M., BRUZZI, P. and MELIOLI, G., A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected non-small cell lung carcinoma. Cancer, 78, 244-251 (1996).
18. ROMAGNANI, S., Induction of Th1 and Th2 response: a key role for the natural immune response. Immunol. Today, 13, 379-381 (1992).
19. ROSENBERG, S.A. and 15 OTHERS, Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. N. Eng. J. Med., 319, 1676-1680 (1988).
20. SUSSMAN, J.J., BONIFACIO, J.S., LIPPINCOTT-SCHWARTZ, J., WEISSMAN, A.M., SAITO, T., KLAUSNER, R.D. and ASHWELL, J.D., Failure to synthesize the T cell CD3-ζ chain: structure and function of a partial T cell receptor complex. Cell, 52, 85-95 (1988).
21. TRAVERSARI, C., VAN DER BRUGGEN, P., LUESCHER, I.K, LURQUIN, C., CHOMEZ, P., VAN PEL, A., DE PLAEN, E., AMAR-COSTESEC, A. and BOON, T., A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. exp. Med., 176, 1453-1457 (1992).
22. ZPA, A.H., CURTI, B.D., LONGO, C.D., ALVORD, W.G., STROBL, S.L., MIZOGUCHI, H., CREEKMORE, S.P., O'SHEA, J.J., POWERS, G.C., URBA, W.J. and OCHOA, A.C., Alterations in T cell receptor and signal transduction molecules in melanoma patients. Clin. Cancer Res., 1, 1327-1335 (1995).